# Aminocamptothecin in Treating Patients With Advanced Cancer of the Peritoneal Cavity

> **NCT00003548** · PHASE1 · COMPLETED · sponsor: **NYU Langone Health** · enrollment: 20 (estimated)

## Conditions studied

- Cancer

## Interventions

- **DRUG:** aminocamptothecin colloidal dispersion

## Key facts

- **NCT ID:** NCT00003548
- **Lead sponsor:** NYU Langone Health
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1998-08
- **Primary completion:** 2001-12
- **Final completion:** —
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2011-03-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00003548

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00003548, "Aminocamptothecin in Treating Patients With Advanced Cancer of the Peritoneal Cavity". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00003548. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*